In this randomized controlled trial in participants with chronic obstructive pulmonary disease, Supine Daoyin improved health status but did not reduce the length of hospital stay.
This Study Summary was published on December 4, 2024.
In this randomized controlled trial in participants with chronic obstructive pulmonary disease, Supine Daoyin improved health status but did not reduce the length of hospital stay.
This Study Summary was published on December 4, 2024.
